Table 1.
Mean arterial blood pressure (mABP; mmHg), plasma glucose (mg/dl), and glycosylated hemoglobin (HbA1c, %)
| Group | mABP (mmHg) | Plasma glucose (mg/dL) | HbA1c (%) |
|---|---|---|---|
| control | 103.1 ± 3.57 | 101.8 ± 4.89 | 3.68 ± 0.17 |
| con+cur300 | 106.18 ± 3.93NS | 106.8 ± 0.92NS | 4.08 ± 0.41NS |
| DM | 151.67 ± 9.68** | 459.0 ± 24.40** | 10.73 ± 0.32** |
| DM+cur30 | 128.33 ± 3.57 | 360.8 ± 35.82** | 8.20 ± 0.88**, † |
| DM+cur300 | 122.27 ± 8.68† | 310.00 ± 32.73**, † | 7.90 ± 0.97**, † |
Values are means ± SEM (n = 10) from the groups of: 12-week STZ (DM), diabetes treated with curcumin (DM+cur30, DM+cur300), controls (con) and controls treated with curcumin (con+cur300). NS, no significant difference compared to control, **P < 0.01, significant difference compared to control and control treated with curcumin; † P < 0.05, significant difference from diabetic rats.